For the First Time Since the Pandemic, Pedestrian Death Rates Fall in the U.S.
Medically reviewed by Drugs.com.
By Physician’s Briefing Staff HealthDay Reporter
TUESDAY, June 25, 2024 -- A total of 7,318 American pedestrians were killed by motor vehicles in 2023 -- a dip of 5.4 percent from 2022 and the first such decline seen since the pandemic ended, according to data released Monday from the Governors Highway Safety Association (GHSA).
However, despite this decline, the 2023 number for pedestrian deaths is still 14.1 percent above prepandemic levels. Still, the news is somewhat heartening, said GHSA Chief Executive Officer Jonathan Adkins.
"A decline in pedestrian deaths offers hope that, after years of rising fatalities, a new trend is starting," he said in a GHSA news release. "Each death is tragic and preventable. We know how to improve safety for people walking -- more infrastructure, vehicles designed to protect people walking, lower speeds, and equitable traffic enforcement. It will take all this, and more, to keep the numbers going in the right direction."
The GHSA report also offered insights into how and where pedestrians are most often killed:
What can be done to bring these numbers down and prevent senseless tragedies on America's roadways? According to the GHSA, "traffic safety cameras and engaging with unhoused populations" who are at particular risk of roadside deaths is crucial. Adding in or repairing sidewalks could also help, as could digital alerts that warn drivers of vehicles parked on the roadside.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-06-26 03:15
Read more
- ACAAI: Many Anaphylaxis Protocols Are Incomplete, Outdated
- Total Hip Replacement Revision Rates Vary With Type of Material Used
- Elevar Therapeutics Announces FDA Acceptance of New Drug Application Resubmission for Rivoceranib in Combination with Camrelizumab as a First-line Systemic Treatment for Unresectable Hepatocellular Carcinoma
- Kids Still Find It Easy to Buy Flavored Vapes Online
- Walking Pneumonia Cases Spike Among Young Kids
- Celldex Announces Barzolvolimab Met All Primary and Secondary Endpoints with High Statistical Significance in Positive Phase 2 Study in Chronic Inducible Urticaria
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions